The FDA recently released the results of their multi-year opioid product quality survey aimed to detect substitutions of illicit fentanyl in the supply chain of FDA-regulated opioids. The FDA reported no evidence of illegal substitution in any FDA-regulated opioids, ingredients used to make opioids, opioid overdose reversal products, and opioid use disorder (OUD) treatment products tested. Cont.
SAMHSA [2/02] - Recently, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced funding opportunities for grant programs aimed at expanding substance use disorder treatment
NIDA | Overdose deaths rose markedly between January to June 2018 and July to December 2021 among 10- to 44-year-old girls and women who were pregnant or pregnant within the previous 12 months. [...]